# Standard BioTools Inc. (LAB) total assets history

URL: https://funkfolio.com/stock/LAB/total-assets

> Standard BioTools Inc. (LAB) total assets were $567.75M at the end of fiscal 2025, down 7.3% from fiscal 2024. Over five fiscal years it grew 11.8% a year.

---

## Standard BioTools Inc. (LAB) total assets

**Total assets · fiscal 2025:** $567.75M at Dec 31, 2025

Standard BioTools Inc. (LAB) had total assets of $567.75M at the end of fiscal 2025 (December 31, 2025). That is 7.3% lower than the $612.35M of fiscal 2024. Figures as of 17 Nov 2026, 21:42 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Total assets, fiscal 2025:** $567.75M
- **Change on fiscal 2024:** −7.3%
- **Growth, 5 years:** +11.8% a year
- **Growth, 10 years:** +4.4% a year
- **Highest on record:** $612.35M fiscal 2024
- **Lowest on record:** $24.80M fiscal 2010
- **Fiscal years on record:** 16 2010–2025

Figures as of 17 Nov 2026, 21:42 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Standard BioTools Inc. total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 11.8% a year; over ten years the rate was 4.4% a year. Across the 16 fiscal years on record (2010–2025), the highest was $612.35M in fiscal 2024 and the lowest $24.80M in fiscal 2010.

### Total assets by fiscal year

### Standard BioTools Inc. total assets, year by year

Standard BioTools Inc. (LAB) total assets by fiscal year

| Fiscal year | Total assets | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $567.75M | 7.3% down | Dec 31, 2025 |
| 2024 | $612.35M | 89.5% up | Dec 31, 2024 |
| 2023 | $323.07M | 17.2% down | Dec 31, 2023 |
| 2022 | $390.31M | 41.8% up | Dec 31, 2022 |
| 2021 | $275.21M | 15.3% down | Dec 31, 2021 |
| 2020 | $324.76M | 22.6% up | Dec 31, 2020 |
| 2019 | $264.81M | 12.8% down | Dec 31, 2019 |
| 2018 | $303.65M | 5.7% up | Dec 31, 2018 |
| 2017 | $287.35M | 6.2% down | Dec 31, 2017 |
| 2016 | $306.40M | 17.2% down | Dec 31, 2016 |
| 2015 | $370.05M | 9.2% down | Dec 31, 2015 |
| 2014 | $407.56M | 248.6% up | Dec 31, 2014 |
| 2013 | $116.92M | 2.8% up | Dec 31, 2013 |
| 2012 | $113.73M | 43.4% up | Dec 31, 2012 |
| 2011 | $79.33M | 219.9% up | Dec 31, 2011 |
| 2010 | $24.80M | — | Dec 31, 2010 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

### How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

### Standard BioTools Inc., figure by figure

- [Standard BioTools Inc. market cap](https://funkfolio.com/stock/LAB/market-cap)
- [Standard BioTools Inc. revenue](https://funkfolio.com/stock/LAB/revenue)
- [Standard BioTools Inc. earnings](https://funkfolio.com/stock/LAB/earnings)
- [Standard BioTools Inc. earnings per share (EPS)](https://funkfolio.com/stock/LAB/eps)
- [Standard BioTools Inc. P/E ratio](https://funkfolio.com/stock/LAB/pe-ratio)
- [Standard BioTools Inc. P/S ratio](https://funkfolio.com/stock/LAB/ps-ratio)
- [Standard BioTools Inc. P/B ratio](https://funkfolio.com/stock/LAB/pb-ratio)
- [Standard BioTools Inc. free cash flow](https://funkfolio.com/stock/LAB/free-cash-flow)
- [Standard BioTools Inc. operating margin](https://funkfolio.com/stock/LAB/operating-margin)
- [Standard BioTools Inc. dividend](https://funkfolio.com/stock/LAB/dividend)
- [Standard BioTools Inc. shares outstanding](https://funkfolio.com/stock/LAB/shares-outstanding)
- [Standard BioTools Inc. total debt](https://funkfolio.com/stock/LAB/total-debt)
- [Standard BioTools Inc. cash on hand](https://funkfolio.com/stock/LAB/cash)
- [Standard BioTools Inc. return on equity (ROE)](https://funkfolio.com/stock/LAB/roe)
- [Standard BioTools Inc. return on invested capital (ROIC)](https://funkfolio.com/stock/LAB/roic)

[Standard BioTools Inc. (LAB) overview: price, valuation and scorecard](https://funkfolio.com/stock/LAB)

### Standard BioTools Inc. total assets: questions and answers

**How large are Standard BioTools Inc.'s total assets?**

Standard BioTools Inc. (LAB) had total assets of $567.75M at the end of fiscal 2025 (December 31, 2025). That is 7.3% lower than the $612.35M of fiscal 2024.

**What is the growth rate of Standard BioTools Inc.'s total assets?**

Over the five fiscal years to 2025 total assets grew at a compound 11.8% a year; over ten years the rate was 4.4% a year.

**What are the highest and lowest total assets figures on record for Standard BioTools Inc.?**

Across the 16 fiscal years on record (2010–2025), the highest was $612.35M in fiscal 2024 and the lowest $24.80M in fiscal 2010.

**How is Standard BioTools Inc.'s total assets calculated?**

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

### Learn: total assets

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Standard BioTools Inc. (LAB) total assets”, data as of 17 November 2026. https://funkfolio.com/stock/LAB/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.
